Clinical trial · Observational
CTP Imaging of Lung Cancer
CTP (Computed Tomography Perfusion) Imaging of Lung Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators hope to learn more about how to use computed tomography (CT) scans to measure blood flow in lung tumors and how it may change in response to treatment. This measurement technique is called computed tomography perfusion (CTP). CT scanners use X-rays to produce 3-dimensional images of the body. Currently, doctors determine the response to treatment by measuring the size of the tumor. Investigators are trying to find out if measuring the blood flow in the tumor is equal to or better than measuring the size of the tumor.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Non Small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- Variability of measurements
- description
- variability of CTP measurements will be determined by repeating the CTP examination, and comparing the resultant blood flow estimates
- label
- Treatment induced effects
- description
- The magnitude of treatment induced effects will be assessed by comparing tumor blood flow estimates before and after treatment
Primary outcomes (1)
- measure
- Yield of conducting CTP studies
- timeFrame
- 2 years
- description
- Yield is determined as the percentage of assessable CTP studies, relative to all performed studies
Secondary outcomes (2)
- measure
- Variability of CTP measurements
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: adult patients with non small cell lung cancer who receive, or are considered for, systemic therapy Exclusion Criteria: renal failure pregnancy known contrast allergy \-
References
Publications (0)
Data not yet available